Recent Blog Articles

Talking to your doctor about your LGBTQ+ sex life

Untangling grief: Living beyond a great loss

Thunderstorm asthma: Bad weather, allergies, and asthma attacks

Heart problems and the heat: What to know and do

I’m too young to have Alzheimer’s disease or dementia, right?

Period equity: What it is and why it matters

Back pain: Will treatment for the mind, body—or both—help?

Colon cancer screening decisions: What’s the best option and when?

Cognitive effects in midlife of long-term cannabis use

If climate change keeps you up at night, here's how to cope
Diseases & Conditions
New recommendations for pneumococcal vaccination
- By Matthew Solan, Executive Editor, Harvard Men's Health Watch
In the journals
The CDC has changed its guidelines for vaccinating adults against pneumococcal disease by approving two new pneumococcal conjugate vaccines (PCVs): PCV15 (Vaxneuvance) and PCV20 (Prevnar 20).
The updated guidelines, published Jan. 28, 2022, in Morbidity and Mortality Weekly Report, apply to adults older than age 65 and younger people at high risk for pneumococcal disease because of a weakened immune system or a chronic medical condition. People can get either vaccine, as the CDC does not endorse one over the other. Pneumococcal disease refers to infections caused by Streptococcus pneumoniae bacteria. Examples include pneumonia, bloodstream infections, ear and sinus infections, and meningitis (swelling of the membranes covering the brain and spinal cord). Previous guidelines recommended two other vaccines: PCV13 and PPSV23. A person who hasn’t received one of these earlier vaccines should have a single dose of the new PCV20 or PCV15, followed a year or more later with a "chaser" of PPSV23. (This period can be shortened to eight weeks for people at high risk.) People who’ve had one of the earlier vaccines should follow these guidelines:
- PPSV23 recipients should have one of the new PCVs at least a year after their PPSV23 vaccination.
- PCV13 recipients don’t need one of the new PCVs at this time, but, if not already received, they should get a PPSV23 vaccination six to 12 months later.
Image; © Prostock-Studio/Getty Images
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
You might also be interested in…

Aging In Place
Aging in Place is the comprehensive planning guide for living safely and independently for as long as possible—wherever you choose to live. You’ll get guidance for modifying a home to meet your changing needs. You’ll read how to ensure comfort and increase convenience and security—without straining your budget. Plus, you’ll find valuable tips for keeping yourself healthy, for deciphering the options of Medicare, for smart financial and legal planning, for utilizing online services, for getting help at home, and so much more.
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!